Trial Outcomes & Findings for Coronavirus Disease of 2019 (COVID-19) Health Education Initiative for School Safety (NCT NCT06938230)
NCT ID: NCT06938230
Last Updated: 2026-01-06
Results Overview
Scores range from 1 ("strongly disagree") to 5 ("strongly agree"), with higher scores indicating more knowledge, value, application, or satisfaction. Evaluation was collected directly after the intervention, at baseline.
COMPLETED
NA
112 participants
Baseline
2026-01-06
Participant Flow
Participant milestones
| Measure |
Health Education Initiative
Participants will receive the health education session for up to 6 months.
Health Education Initiative: Participants will receive a one time 45 minute intervention session. During the session participants will receive information regarding COVID-19 disease process and behavioral effects and had the opportunity to ask questions.
|
Control Group
Participants in this group will not receive any health education and total participation is up to 6 months.
|
|---|---|---|
|
Overall Study
STARTED
|
76
|
36
|
|
Overall Study
COMPLETED
|
20
|
18
|
|
Overall Study
NOT COMPLETED
|
56
|
18
|
Reasons for withdrawal
| Measure |
Health Education Initiative
Participants will receive the health education session for up to 6 months.
Health Education Initiative: Participants will receive a one time 45 minute intervention session. During the session participants will receive information regarding COVID-19 disease process and behavioral effects and had the opportunity to ask questions.
|
Control Group
Participants in this group will not receive any health education and total participation is up to 6 months.
|
|---|---|---|
|
Overall Study
Lost to Follow-up
|
56
|
18
|
Baseline Characteristics
There were only 64 participants analyzed because the remaining participants did not respond to the question.
Baseline characteristics by cohort
| Measure |
Health Education Initiative
n=76 Participants
Participants will receive the health education session for up to 6 months.
Health Education Initiative: Participants will receive a one time 45 minute intervention session. During the session participants will receive information regarding COVID-19 disease process and behavioral effects and had the opportunity to ask questions.
|
Control Group
n=36 Participants
Participants in this group will not receive any health education and total participation is up to 6 months.
|
Total
n=112 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
44.34 years
STANDARD_DEVIATION 8.80 • n=29 Participants • There were only 64 participants analyzed because the remaining participants did not respond to the question.
|
41.69 years
STANDARD_DEVIATION 7.85 • n=35 Participants • There were only 64 participants analyzed because the remaining participants did not respond to the question.
|
42.89 years
STANDARD_DEVIATION 8.14 • n=64 Participants • There were only 64 participants analyzed because the remaining participants did not respond to the question.
|
|
Sex: Female, Male
Female
|
26 Participants
n=29 Participants • There were only 65 participants analyzed, because the remaining participants did not respond to the question.
|
32 Participants
n=36 Participants • There were only 65 participants analyzed, because the remaining participants did not respond to the question.
|
58 Participants
n=65 Participants • There were only 65 participants analyzed, because the remaining participants did not respond to the question.
|
|
Sex: Female, Male
Male
|
3 Participants
n=29 Participants • There were only 65 participants analyzed, because the remaining participants did not respond to the question.
|
4 Participants
n=36 Participants • There were only 65 participants analyzed, because the remaining participants did not respond to the question.
|
7 Participants
n=65 Participants • There were only 65 participants analyzed, because the remaining participants did not respond to the question.
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
7 Participants
n=76 Participants
|
5 Participants
n=36 Participants
|
12 Participants
n=112 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
17 Participants
n=76 Participants
|
31 Participants
n=36 Participants
|
48 Participants
n=112 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
52 Participants
n=76 Participants
|
0 Participants
n=36 Participants
|
52 Participants
n=112 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=76 Participants
|
0 Participants
n=36 Participants
|
0 Participants
n=112 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=76 Participants
|
1 Participants
n=36 Participants
|
1 Participants
n=112 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=76 Participants
|
0 Participants
n=36 Participants
|
0 Participants
n=112 Participants
|
|
Race (NIH/OMB)
Black or African American
|
18 Participants
n=76 Participants
|
28 Participants
n=36 Participants
|
46 Participants
n=112 Participants
|
|
Race (NIH/OMB)
White
|
8 Participants
n=76 Participants
|
5 Participants
n=36 Participants
|
13 Participants
n=112 Participants
|
|
Race (NIH/OMB)
More than one race
|
1 Participants
n=76 Participants
|
0 Participants
n=36 Participants
|
1 Participants
n=112 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
49 Participants
n=76 Participants
|
2 Participants
n=36 Participants
|
51 Participants
n=112 Participants
|
PRIMARY outcome
Timeframe: BaselinePopulation: This was data collection only for the health education initiative. The control group did not participate in this section.
Scores range from 1 ("strongly disagree") to 5 ("strongly agree"), with higher scores indicating more knowledge, value, application, or satisfaction. Evaluation was collected directly after the intervention, at baseline.
Outcome measures
| Measure |
Health Education Initiative
n=76 Participants
Participants will receive the health education session for up to 6 months.
Health Education Initiative: Participants will receive a one time 45 minute intervention session. During the session participants will receive information regarding COVID-19 disease process and behavioral effects and had the opportunity to ask questions.
|
Control Group
Participants in this group will not receive any health education and total participation is up to 6 months.
|
|---|---|---|
|
Evaluation of Acceptability of Intervention as Measured by Acceptability Questionnaire
|
4.47 score on a scale
Standard Deviation 0.89
|
—
|
PRIMARY outcome
Timeframe: 6 monthsPopulation: This was only administered to the intervention group. No control participants were analyzed because they did not receive this measure.
Scores range from 1 ("strongly disagree") to 5 ("strongly agree"), with higher scores indicating more knowledge, value, application, or satisfaction.
Outcome measures
| Measure |
Health Education Initiative
n=76 Participants
Participants will receive the health education session for up to 6 months.
Health Education Initiative: Participants will receive a one time 45 minute intervention session. During the session participants will receive information regarding COVID-19 disease process and behavioral effects and had the opportunity to ask questions.
|
Control Group
Participants in this group will not receive any health education and total participation is up to 6 months.
|
|---|---|---|
|
Evaluation of Confidence in COVID Healthcare Decision Making as Measured by COVID Confidence Questionnaire
|
4.38 score on a scale
Standard Deviation 0.86
|
—
|
PRIMARY outcome
Timeframe: BaselinePopulation: The number of participants analyzed at 6 months is lower than those who were analyzed at baseline due to participants lost to follow-up.
The unit of measure is the number of caregivers who received COVID-19 vaccine at baseline
Outcome measures
| Measure |
Health Education Initiative
n=49 Participants
Participants will receive the health education session for up to 6 months.
Health Education Initiative: Participants will receive a one time 45 minute intervention session. During the session participants will receive information regarding COVID-19 disease process and behavioral effects and had the opportunity to ask questions.
|
Control Group
n=34 Participants
Participants in this group will not receive any health education and total participation is up to 6 months.
|
|---|---|---|
|
Number of Caregivers Who Received COVID-19 Vaccine
|
35 Participants
|
24 Participants
|
PRIMARY outcome
Timeframe: BaselinePopulation: The number of participants analyzed at baseline differs from the number analyzed at 6 months because participants were lost to follow-up.
unit of measure number of children
Outcome measures
| Measure |
Health Education Initiative
n=52 Participants
Participants will receive the health education session for up to 6 months.
Health Education Initiative: Participants will receive a one time 45 minute intervention session. During the session participants will receive information regarding COVID-19 disease process and behavioral effects and had the opportunity to ask questions.
|
Control Group
n=35 Participants
Participants in this group will not receive any health education and total participation is up to 6 months.
|
|---|---|---|
|
Number of Children Who Received COVID-19 Vaccine
|
23 Participants
|
18 Participants
|
PRIMARY outcome
Timeframe: BaselinePopulation: The number of participants analyzed differ between baseline and 6 months because participants were lost to follow-up.
Scores range from 1 ("strongly disagree") to 5 ("strongly agree"), with higher scores indicating greater intent to engage in health behaviors to prevent COVID-19.
Outcome measures
| Measure |
Health Education Initiative
n=61 Participants
Participants will receive the health education session for up to 6 months.
Health Education Initiative: Participants will receive a one time 45 minute intervention session. During the session participants will receive information regarding COVID-19 disease process and behavioral effects and had the opportunity to ask questions.
|
Control Group
n=34 Participants
Participants in this group will not receive any health education and total participation is up to 6 months.
|
|---|---|---|
|
Health Behaviors as Measured by Health Behavior Questionnaire
|
4.10 score on a scale
Standard Deviation 1.10
|
3.76 score on a scale
Standard Deviation 1.37
|
PRIMARY outcome
Timeframe: 6 monthsPopulation: The number of participants analyzed at 6 months is lower than those who were analyzed at baseline due to participants lost to follow-up.
The unit of measure is the number of caregivers who received COVID-19 vaccine
Outcome measures
| Measure |
Health Education Initiative
n=29 Participants
Participants will receive the health education session for up to 6 months.
Health Education Initiative: Participants will receive a one time 45 minute intervention session. During the session participants will receive information regarding COVID-19 disease process and behavioral effects and had the opportunity to ask questions.
|
Control Group
n=17 Participants
Participants in this group will not receive any health education and total participation is up to 6 months.
|
|---|---|---|
|
Number of Caregivers Who Received COVID-19 Vaccine
|
18 Participants
|
7 Participants
|
PRIMARY outcome
Timeframe: 6 monthPopulation: The number of participants analyzed differ between baseline and 6 months because participants were lost to follow-up.
Scores range from 1 ("strongly disagree") to 5 ("strongly agree"), with higher scores indicating greater intent to engage in health behaviors to prevent COVID-19.
Outcome measures
| Measure |
Health Education Initiative
n=33 Participants
Participants will receive the health education session for up to 6 months.
Health Education Initiative: Participants will receive a one time 45 minute intervention session. During the session participants will receive information regarding COVID-19 disease process and behavioral effects and had the opportunity to ask questions.
|
Control Group
n=18 Participants
Participants in this group will not receive any health education and total participation is up to 6 months.
|
|---|---|---|
|
Health Behaviors as Measured by Health Behavior Questionnaire
|
4.09 score on a scale
Standard Deviation 0.82
|
3.96 score on a scale
Standard Deviation 1.18
|
PRIMARY outcome
Timeframe: 6 monthsPopulation: The number of participants analyzed at baseline differs from the number analyzed at 6 months because participants were lost to follow-up.
unit of measure number of children
Outcome measures
| Measure |
Health Education Initiative
n=28 Participants
Participants will receive the health education session for up to 6 months.
Health Education Initiative: Participants will receive a one time 45 minute intervention session. During the session participants will receive information regarding COVID-19 disease process and behavioral effects and had the opportunity to ask questions.
|
Control Group
n=16 Participants
Participants in this group will not receive any health education and total participation is up to 6 months.
|
|---|---|---|
|
Number of Children Who Received COVID-19 Vaccine
|
11 Participants
|
5 Participants
|
SECONDARY outcome
Timeframe: Baseline, 6 month follow upPopulation: The number of participants analyzed at baseline is lower than the overall number of participants, because some participants did not complete their packet of questionnaires, including the present measure. There were fewer participants at the 6-month follow-up because participants were lost to follow-up.
Individual item scores range from 0 to 4, individual total sum scores range from 0 to 44 higher scores indicate more symptoms of PTSD. Total sum score ranging from 1-10 is considered "minimal PTSD", total sum score ranging from 11-20 is considered "mild PTSD", total sum scores of 21 or more is considered "potential PTSD".
Outcome measures
| Measure |
Health Education Initiative
n=29 Participants
Participants will receive the health education session for up to 6 months.
Health Education Initiative: Participants will receive a one time 45 minute intervention session. During the session participants will receive information regarding COVID-19 disease process and behavioral effects and had the opportunity to ask questions.
|
Control Group
n=35 Participants
Participants in this group will not receive any health education and total participation is up to 6 months.
|
|---|---|---|
|
PTSD as Measured by the University of California Los Angeles (UCLA) Brief COVID-19 Screen for Child/Adolescent Post Traumatic Stress Disorder (PTSD)
6 month follow up
|
4.6 score on a scale
Standard Deviation 6.7
|
7.74 score on a scale
Standard Deviation 8.27
|
|
PTSD as Measured by the University of California Los Angeles (UCLA) Brief COVID-19 Screen for Child/Adolescent Post Traumatic Stress Disorder (PTSD)
Baseline
|
5.83 score on a scale
Standard Deviation 6.49
|
5.77 score on a scale
Standard Deviation 8.63
|
SECONDARY outcome
Timeframe: Baseline, 6 month follow upPopulation: The number of participants analyzed at baseline is lower than the overall number of participants, because some participants did not complete their packet of questionnaires, including the present measure. There were fewer participants at the 6-month follow-up because participants were lost to follow-up.
individual item score ranges from 0 to 4, individual total sum scores range from 0 to 20 higher scores indicate more symptoms of COVID specific anxiety. Total sum scores of greater than of equal to 9 equals "probable dysfunctional Coronavirus related anxiety".
Outcome measures
| Measure |
Health Education Initiative
n=29 Participants
Participants will receive the health education session for up to 6 months.
Health Education Initiative: Participants will receive a one time 45 minute intervention session. During the session participants will receive information regarding COVID-19 disease process and behavioral effects and had the opportunity to ask questions.
|
Control Group
n=35 Participants
Participants in this group will not receive any health education and total participation is up to 6 months.
|
|---|---|---|
|
COVID Anxiety as Measured by the Coronavirus Anxiety Scale
Baseline
|
0.21 score on a scale
Standard Deviation 0.62
|
1.37 score on a scale
Standard Deviation 3.95
|
|
COVID Anxiety as Measured by the Coronavirus Anxiety Scale
6 month follow up
|
0.83 score on a scale
Standard Deviation 2.28
|
0.42 score on a scale
Standard Deviation 1.22
|
Adverse Events
Health Education Initiative
Control Group
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place